Loading clinical trials...
Loading clinical trials...
This study is designed to demonstrate non-inferior immunogenicity of 3 doses of the 9-Valent Human Papillomavirus (9vHPV) vaccine (GARDASIL™9, V503) in Chinese males 9 through 19 years of age, and 2 d...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Merck Sharp & Dohme LLC
NCT02750202 · Genital Warts
NCT00092534 · Cervical Cancer, Genital Warts
NCT06915779 · Cervical Cancer, Human Papillomavirus Infection, and more
NCT06700941 · Cervical Intraepithelial Neoplasia (CIN), Genital Warts, and more
NCT06691542 · Non-Genital Warts
Liucheng County Centers for Disease Control and Prevention ( Site 0005)
Liuchow, Guangxi
Center for Disease Control and Prevention of Rong An ( Site 0006)
Liuchow, Guangxi
Loudi Public Health Hospital (Loudi Occupational Disease Prevention And Treatment Hospital) ( Site 0
Louxing District, Hunan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions